272 related articles for article (PubMed ID: 32985167)
1. [Mechanisms underlying remyelination with special focus on demyelination models of multiple sclerosis].
Zheng S; Zhao J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 49(4):524-530. PubMed ID: 32985167
[TBL] [Abstract][Full Text] [Related]
2. Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
Tepavčević V; Lubetzki C
Brain; 2022 Dec; 145(12):4178-4192. PubMed ID: 36093726
[TBL] [Abstract][Full Text] [Related]
3. Myt1L Promotes Differentiation of Oligodendrocyte Precursor Cells and is Necessary for Remyelination After Lysolecithin-Induced Demyelination.
Shi Y; Shao Q; Li Z; Gonzalez GA; Lu F; Wang D; Pu Y; Huang A; Zhao C; He C; Cao L
Neurosci Bull; 2018 Apr; 34(2):247-260. PubMed ID: 29397565
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases shape the oligodendrocyte (niche) during development and upon demyelination.
Gorter RP; Baron W
Neurosci Lett; 2020 Jun; 729():134980. PubMed ID: 32315713
[TBL] [Abstract][Full Text] [Related]
5. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
[TBL] [Abstract][Full Text] [Related]
6. Donepezil, a drug for Alzheimer's disease, promotes oligodendrocyte generation and remyelination.
Cui X; Guo YE; Fang JH; Shi CJ; Suo N; Zhang R; Xie X
Acta Pharmacol Sin; 2019 Nov; 40(11):1386-1393. PubMed ID: 30918344
[TBL] [Abstract][Full Text] [Related]
7. Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
Mei F; Mayoral SR; Nobuta H; Wang F; Desponts C; Lorrain DS; Xiao L; Green AJ; Rowitch D; Whistler J; Chan JR
J Neurosci; 2016 Jul; 36(30):7925-35. PubMed ID: 27466337
[TBL] [Abstract][Full Text] [Related]
8. The adult oligodendrocyte can participate in remyelination.
Duncan ID; Radcliff AB; Heidari M; Kidd G; August BK; Wierenga LA
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11807-E11816. PubMed ID: 30487224
[TBL] [Abstract][Full Text] [Related]
9. Oligodendrocytes in Development, Myelin Generation and Beyond.
Kuhn S; Gritti L; Crooks D; Dombrowski Y
Cells; 2019 Nov; 8(11):. PubMed ID: 31726662
[TBL] [Abstract][Full Text] [Related]
10. Chronic demyelination of rabbit lesions is attributable to failed oligodendrocyte progenitor cell repopulation.
Cooper JJM; Polanco JJ; Saraswat D; Peirick JJ; Seidl A; Li Y; Ma D; Sim FJ
Glia; 2023 Apr; 71(4):1018-1035. PubMed ID: 36537341
[TBL] [Abstract][Full Text] [Related]
11. Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases.
Skaper SD
Prog Brain Res; 2019; 245():119-144. PubMed ID: 30961866
[TBL] [Abstract][Full Text] [Related]
12. Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination.
Chen Y; Zhen W; Guo T; Zhao Y; Liu A; Rubio JP; Krull D; Richardson JC; Lu H; Wang R
PLoS One; 2017; 12(12):e0189380. PubMed ID: 29253893
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of Protein Tyrosine Phosphatase Receptor Type Z by Pleiotrophin Promotes Remyelination through Activation of Differentiation of Oligodendrocyte Precursor Cells.
Kuboyama K; Fujikawa A; Suzuki R; Noda M
J Neurosci; 2015 Sep; 35(35):12162-71. PubMed ID: 26338327
[TBL] [Abstract][Full Text] [Related]
14. Myelin regulatory factor drives remyelination in multiple sclerosis.
Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
[TBL] [Abstract][Full Text] [Related]
15. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
[TBL] [Abstract][Full Text] [Related]
16. Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination.
Coppolino GT; Marangon D; Negri C; Menichetti G; Fumagalli M; Gelosa P; Dimou L; Furlan R; Lecca D; Abbracchio MP
Glia; 2018 May; 66(5):1118-1130. PubMed ID: 29424466
[TBL] [Abstract][Full Text] [Related]
17. Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models.
Boyd A; Zhang H; Williams A
Acta Neuropathol; 2013 Jun; 125(6):841-59. PubMed ID: 23595275
[TBL] [Abstract][Full Text] [Related]
18. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
19. CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis.
Wang L; Yang H; Zang C; Dong Y; Shang J; Chen J; Wang Y; Liu H; Zhang Z; Xu H; Bao X; Zhang D
Neurobiol Dis; 2020 Feb; 134():104630. PubMed ID: 31678404
[TBL] [Abstract][Full Text] [Related]
20. GD1a Overcomes Inhibition of Myelination by Fibronectin via Activation of Protein Kinase A: Implications for Multiple Sclerosis.
Qin J; Sikkema AH; van der Bij K; de Jonge JC; Klappe K; Nies V; Jonker JW; Kok JW; Hoekstra D; Baron W
J Neurosci; 2017 Oct; 37(41):9925-9938. PubMed ID: 28899916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
